Market Research of Medicinal and Cosmetic Products for Various Forms of Alopecia

The document discussed the issue of alopecia, particularly androgenic and telogen alopecia, highlighting the prevalence of uncontrolled cosmetic product use for hair loss among young people in Ukraine. It noted a significant decrease in registered medicinal remedies for alopecia and dandruff, with a 36% and 17% reduction, respectively, since 2012. The market was dominated by foreign-made drugs, primarily from India, Germany, and France, which constituted 77% of the total and increased costs. The document emphasized the need for developing effective, safe, plant-based medicines to address alopecia's pathogenic mechanisms, as current treatments like minoxidil and finasteride have drawbacks and side effects.